Machine learning in genomics

Two new Max Planck tools target the 60% to 70% of sequenced patients left undiagnosed

Martin Vingron's lab has published two algorithms for the variant classes that short-read pipelines handle worst. The validation detail in both reports is thin, so diagnostic labs will have to test them.